Neurizon Therapeutics Ltd has received FDA clearance for its lead candidate, NUZ-001, to enter the HEALEY ALS Platform Trial ...
A Heriot-Watt University researcher has secured £2 million in funding to develop quantum sensors capable of watching immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback